Last 12 months
Inside the activity.
0 purchase rows · 19 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 8 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 03, 2021 Filed Jun 3, 2021 22:38 UTC |
SWINNEY ROBERT SDirector
|
Exercise / conversionCommon Stock | 1,500 | $39.38 | $59,070.00 |
DisclosureSEC source: 0001073398-21-000005 · edgardoc.xml · nonDerivative · entry 2 SWINNEY ROBERT S · CIK 0001073398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,473 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 03, 2021 Filed Jun 3, 2021 22:38 UTC |
SWINNEY ROBERT SDirector
|
Exercise / conversionCommon Stock | 1,500 | $43.62 | $65,430.00 |
DisclosureSEC source: 0001073398-21-000005 · edgardoc.xml · nonDerivative · entry 1 SWINNEY ROBERT S · CIK 0001073398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,973 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2021 Filed May 24, 2021 15:28 UTC |
Jain VivekDirector · Chairman and CEO
|
GiftCommon Stock | 40 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-21-000007 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,779 F1 · price: Shares transferred as a bona fide gift without any consideration. Read SEC document |
| May 20, 2021 Filed May 24, 2021 15:28 UTC |
Jain VivekDirector · Chairman and CEO
|
GiftCommon Stock | 25 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-21-000007 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,819 F1 · price: Shares transferred as a bona fide gift without any consideration. Read SEC document |
| May 11, 2021 Filed May 12, 2021 18:55 UTC |
Hoffmeister David FDirector
|
GrantNon-Qualified Stock Options (right to buy) · Derivative | 1,295 | $0.00 Strike: $196.57 | $0.00 |
DisclosureSEC source: 0001209191-21-032003 · doc4.xml · derivative · entry 4 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,295 Underlying: Common Stock · 1,295 shares Expires 2032-05-11 F4 · derivative.exercise_date: These options vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first. Read SEC document |
| May 11, 2021 Filed May 12, 2021 18:55 UTC |
Hoffmeister David FDirector
|
GrantCommon Stock · Derivative | 433 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-032003 · doc4.xml · derivative · entry 3 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 433 Underlying: Common Stock · 433 shares Expires 2022-05-11 F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first. Read SEC document |
| May 11, 2021 Filed May 12, 2021 18:55 UTC |
Hoffmeister David FDirector
|
Exercise / conversionCommon Stock · Derivative | 468 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-032003 · doc4.xml · derivative · entry 2 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 468 shares Expires 2021-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first. Read SEC document |
| May 11, 2021 Filed May 12, 2021 18:55 UTC |
Hoffmeister David FDirector
|
Exercise / conversionCommon Stock | 468 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-032003 · doc4.xml · nonDerivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,161 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| May 11, 2021 Filed May 12, 2021 18:08 UTC |
Abbey DonaldDirector
|
GrantNon-Qualified Stock Options (right to buy) · Derivative | 1,295 | $0.00 Strike: $196.57 | $0.00 |
DisclosureSEC source: 0001209191-21-031993 · doc4.xml · derivative · entry 4 Abbey Donald · CIK 0001534342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,295 Underlying: Common Stock · 1,295 shares Expires 2032-05-11 F4 · derivative.exercise_date: These options vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first. Read SEC document |
| May 11, 2021 Filed May 12, 2021 18:08 UTC |
Abbey DonaldDirector
|
GrantCommon Stock · Derivative | 433 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-031993 · doc4.xml · derivative · entry 3 Abbey Donald · CIK 0001534342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 433 Underlying: Common Stock · 433 shares Expires 2022-05-11 F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first. Read SEC document |
| May 11, 2021 Filed May 12, 2021 18:08 UTC |
Abbey DonaldDirector
|
Exercise / conversionCommon Stock · Derivative | 468 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-031993 · doc4.xml · derivative · entry 2 Abbey Donald · CIK 0001534342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 468 shares Expires 2021-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first. Read SEC document |
| May 11, 2021 Filed May 12, 2021 18:08 UTC |
Abbey DonaldDirector
|
Exercise / conversionCommon Stock | 468 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-031993 · doc4.xml · nonDerivative · entry 1 Abbey Donald · CIK 0001534342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,161 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| May 11, 2021 Filed May 12, 2021 17:45 UTC |
SWINNEY ROBERT SDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 1,295 | $0.00 Strike: $196.57 | $0.00 |
DisclosureSEC source: 0001073398-21-000004 · edgardoc.xml · derivative · entry 5 SWINNEY ROBERT S · CIK 0001073398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,295 Underlying: Common Stock · 1,295 shares Expires 2031-05-11 F4 · derivative.exercise_date: These stock options vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first. Read SEC document |
| May 11, 2021 Filed May 12, 2021 17:45 UTC |
SWINNEY ROBERT SDirector
|
GrantCommon Stock · Derivative | 433 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001073398-21-000004 · edgardoc.xml · derivative · entry 4 SWINNEY ROBERT S · CIK 0001073398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 433 Underlying: Common Stock · 433 shares Expires 2022-05-11 F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first. Read SEC document |
| May 11, 2021 Filed May 12, 2021 17:45 UTC |
SWINNEY ROBERT SDirector
|
Exercise / conversionCommon Stock · Derivative | 468 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001073398-21-000004 · edgardoc.xml · derivative · entry 3 SWINNEY ROBERT S · CIK 0001073398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 468 shares Expires 2021-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first. Read SEC document |
| May 11, 2021 Filed May 12, 2021 17:45 UTC |
SWINNEY ROBERT SDirector
|
Exercise / conversionCommon Stock | 468 | $0.00 | $0.00 |
DisclosureSEC source: 0001073398-21-000004 · edgardoc.xml · nonDerivative · entry 1 SWINNEY ROBERT S · CIK 0001073398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,473 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| May 11, 2021 Filed May 12, 2021 17:41 UTC |
Greenberg David C.Director
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 1,295 | $0.00 Strike: $196.57 | $0.00 |
DisclosureSEC source: 0001645866-21-000001 · edgardoc.xml · derivative · entry 5 Greenberg David C. · CIK 0001645866 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,295 Underlying: Common Stock · 1,295 shares Expires 2031-05-11 F4 · derivative.exercise_date: These stock options vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first. Read SEC document |
| May 11, 2021 Filed May 12, 2021 17:41 UTC |
Greenberg David C.Director
|
GrantCommon Stock · Derivative | 433 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001645866-21-000001 · edgardoc.xml · derivative · entry 4 Greenberg David C. · CIK 0001645866 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 433 Underlying: Common Stock · 433 shares Expires 2022-05-11 F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first. Read SEC document |
| May 11, 2021 Filed May 12, 2021 17:41 UTC |
Greenberg David C.Director
|
Exercise / conversionCommon Stock · Derivative | 468 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001645866-21-000001 · edgardoc.xml · derivative · entry 3 Greenberg David C. · CIK 0001645866 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 468 shares Expires 2021-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first. Read SEC document |
| May 11, 2021 Filed May 12, 2021 17:41 UTC |
Greenberg David C.Director
|
Exercise / conversionCommon Stock | 468 | $0.00 | $0.00 |
DisclosureSEC source: 0001645866-21-000001 · edgardoc.xml · nonDerivative · entry 1 Greenberg David C. · CIK 0001645866 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,171 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| May 11, 2021 Filed May 12, 2021 14:18 UTC |
Sanzone Virginia RuthVP, General Counsel
|
SaleCommon Stock | 983 | $200.11 | $196,707.15 |
DisclosureSEC source: 0001669639-21-000004 · edgardoc.xml · nonDerivative · entry 1 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,405 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from 200.02 to $200.32, inclusive. The reporting person undertakes to provide ICU Medical,Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the range set forth in this Form 4. Read SEC document |
| May 11, 2021 Filed May 13, 2021 21:05 UTC |
FINNEY ELISHA WDirector
|
GrantNon-qualified Stock Option · Derivative | 1,295 | $0.00 Strike: $196.57 | $0.00 |
DisclosureSEC source: 0001209191-21-032382 · doc4.xml · derivative · entry 4 FINNEY ELISHA W · CIK 0001217439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,295 Underlying: Common Stock · 1,295 shares Expires 2032-05-11 F4 · derivative.exercise_date: These options vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first. Read SEC document |
| May 11, 2021 Filed May 13, 2021 21:05 UTC |
FINNEY ELISHA WDirector
|
GrantCommon Stock · Derivative | 433 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-032382 · doc4.xml · derivative · entry 3 FINNEY ELISHA W · CIK 0001217439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 433 Underlying: Common Stock · 433 shares Expires 2022-05-11 F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first. Read SEC document |
| May 11, 2021 Filed May 13, 2021 21:05 UTC |
FINNEY ELISHA WDirector
|
Exercise / conversionCommon Stock · Derivative | 468 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-032382 · doc4.xml · derivative · entry 2 FINNEY ELISHA W · CIK 0001217439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 468 shares Expires 2021-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first. Read SEC document |
| May 11, 2021 Filed May 13, 2021 21:05 UTC |
FINNEY ELISHA WDirector
|
Exercise / conversionCommon Stock | 468 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-032382 · doc4.xml · nonDerivative · entry 1 FINNEY ELISHA W · CIK 0001217439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,951 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| April 23, 2021 Filed Apr 30, 2021 20:57 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 11 | $214.64 | $2,361.04 |
DisclosureSEC source: 0001073397-21-000004 · edgardoc.xml · nonDerivative · entry 7 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Partnership Disclosed balance after: 886,843 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2021. F8 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| April 23, 2021 Filed Apr 30, 2021 20:57 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 3,529 | $213.79 | $754,479.73 |
DisclosureSEC source: 0001073397-21-000004 · edgardoc.xml · nonDerivative · entry 6 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Partnership Disclosed balance after: 886,854 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2021. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $213.55 to $213.97, inclusive. The reporting person undertakes to provide ICU Medical,Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the range set forth in this Form 4. Read SEC document |
| April 23, 2021 Filed Apr 30, 2021 20:57 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 6,804 | $213.04 | $1,449,550.02 |
DisclosureSEC source: 0001073397-21-000004 · edgardoc.xml · nonDerivative · entry 5 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Partnership Disclosed balance after: 890,383 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2021. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $212.55 to $213.52, inclusive. The reporting person undertakes to provide ICU Medical,Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the range set forth in this Form 4. Read SEC document |
| April 23, 2021 Filed Apr 30, 2021 20:57 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 2,671 | $211.82 | $565,770.95 |
DisclosureSEC source: 0001073397-21-000004 · edgardoc.xml · nonDerivative · entry 4 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Partnership Disclosed balance after: 897,187 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2021. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $211.48 to $212.45, inclusive. The reporting person undertakes to provide ICU Medical,Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the range set forth in this Form 4. Read SEC document |
| April 22, 2021 Filed Apr 30, 2021 20:57 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 1,970 | $215.29 | $424,120.51 |
DisclosureSEC source: 0001073397-21-000004 · edgardoc.xml · nonDerivative · entry 3 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Partnership Disclosed balance after: 899,858 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2021. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $215.16 to $215.78, inclusive. The reporting person undertakes to provide ICU Medical,Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the range set forth in this Form 4. Read SEC document |
| April 22, 2021 Filed Apr 30, 2021 20:57 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 4,926 | $214.64 | $1,057,296.94 |
DisclosureSEC source: 0001073397-21-000004 · edgardoc.xml · nonDerivative · entry 2 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Partnership Disclosed balance after: 901,828 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2021. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $214.14 to $215.13, inclusive. The reporting person undertakes to provide ICU Medical,Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the range set forth in this Form 4. Read SEC document |
| April 22, 2021 Filed Apr 30, 2021 20:57 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 5,089 | $213.58 | $1,086,913.71 |
DisclosureSEC source: 0001073397-21-000004 · edgardoc.xml · nonDerivative · entry 1 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Partnership Disclosed balance after: 906,754 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $213.09 to $214.08, inclusive. The reporting person undertakes to provide ICU Medical,Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the range set forth in this Form 4. Read SEC document |
| April 16, 2021 Filed Apr 16, 2021 23:59 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 1,559 | $212.78 | $331,726.83 |
DisclosureSEC source: 0001073397-21-000003 · edgardoc.xml · nonDerivative · entry 10 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Partnership Disclosed balance after: 911,843 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2021. F11 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $212.52 to 213.17, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| April 16, 2021 Filed Apr 16, 2021 23:59 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 1,905 | $211.81 | $403,498.05 |
DisclosureSEC source: 0001073397-21-000003 · edgardoc.xml · nonDerivative · entry 9 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Partnership Disclosed balance after: 913,402 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2021. F10 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $211.45 to 212.44, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| April 16, 2021 Filed Apr 16, 2021 23:59 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 1,608 | $211.03 | $339,335.28 |
DisclosureSEC source: 0001073397-21-000003 · edgardoc.xml · nonDerivative · entry 8 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Partnership Disclosed balance after: 915,307 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2021. F9 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $210.44 to 211.39, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| April 16, 2021 Filed Apr 16, 2021 23:59 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 2,597 | $210.01 | $545,393.89 |
DisclosureSEC source: 0001073397-21-000003 · edgardoc.xml · nonDerivative · entry 7 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Partnership Disclosed balance after: 916,915 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2021. F8 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $209.43 to 210.37, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| April 16, 2021 Filed Apr 16, 2021 23:59 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 977 | $208.79 | $203,983.63 |
DisclosureSEC source: 0001073397-21-000003 · edgardoc.xml · nonDerivative · entry 6 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Partnership Disclosed balance after: 919,512 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2021. F7 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $208.28 to 209.19, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| April 16, 2021 Filed Apr 16, 2021 23:59 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 1,454 | $207.65 | $301,924.70 |
DisclosureSEC source: 0001073397-21-000003 · edgardoc.xml · nonDerivative · entry 5 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Partnership Disclosed balance after: 920,489 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2021. F6 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $207.13 to 207.93, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| April 15, 2021 Filed Apr 16, 2021 23:59 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 200 | $209.31 | $41,862.00 |
DisclosureSEC source: 0001073397-21-000003 · edgardoc.xml · nonDerivative · entry 4 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Partnership Disclosed balance after: 921,943 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2021. F5 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| April 15, 2021 Filed Apr 16, 2021 23:59 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 5,658 | $208.62 | $1,180,352.72 |
DisclosureSEC source: 0001073397-21-000003 · edgardoc.xml · nonDerivative · entry 3 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Partnership Disclosed balance after: 922,143 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2021. F4 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $208.23 to 209.11, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| April 15, 2021 Filed Apr 16, 2021 23:59 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 8,412 | $207.68 | $1,746,994.07 |
DisclosureSEC source: 0001073397-21-000003 · edgardoc.xml · nonDerivative · entry 2 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Partnership Disclosed balance after: 927,801 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2021. F3 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $207.22 to 208.21, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| April 15, 2021 Filed Apr 16, 2021 23:59 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 630 | $206.71 | $130,226.92 |
DisclosureSEC source: 0001073397-21-000003 · edgardoc.xml · nonDerivative · entry 1 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Partnership Disclosed balance after: 936,213 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2021. F2 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $206.15 to 207.13, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| April 12, 2021 Filed Apr 12, 2021 22:24 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 384 | $206.78 | $79,402.10 |
DisclosureSEC source: 0001073397-21-000002 · edgardoc.xml · nonDerivative · entry 9 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Partnership Disclosed balance after: 936,843 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2021. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $206.48 to $207.03, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| April 12, 2021 Filed Apr 12, 2021 22:24 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 4,149 | $206.10 | $855,128.40 |
DisclosureSEC source: 0001073397-21-000002 · edgardoc.xml · nonDerivative · entry 8 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Partnership Disclosed balance after: 937,227 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2021. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $205.47 to $206.45, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| April 12, 2021 Filed Apr 12, 2021 22:24 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 167 | $205.23 | $34,272.68 |
DisclosureSEC source: 0001073397-21-000002 · edgardoc.xml · nonDerivative · entry 7 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Partnership Disclosed balance after: 941,376 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2021. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $204.43 to $205.34, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| April 09, 2021 Filed Apr 12, 2021 22:24 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 400 | $204.70 | $81,880.00 |
DisclosureSEC source: 0001073397-21-000002 · edgardoc.xml · nonDerivative · entry 6 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Partnership Disclosed balance after: 941,543 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2021. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $204.55 to $204.82, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| April 09, 2021 Filed Apr 12, 2021 22:24 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 5,350 | $203.84 | $1,090,560.59 |
DisclosureSEC source: 0001073397-21-000002 · edgardoc.xml · nonDerivative · entry 5 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Partnership Disclosed balance after: 941,943 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2021. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $203.52 to $204.23, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| April 09, 2021 Filed Apr 12, 2021 22:24 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 4,650 | $203.11 | $944,449.88 |
DisclosureSEC source: 0001073397-21-000002 · edgardoc.xml · nonDerivative · entry 4 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Partnership Disclosed balance after: 947,293 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2021. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.52 to $203.51, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| April 08, 2021 Filed Apr 12, 2021 22:24 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 1,118 | $204.99 | $229,178.93 |
DisclosureSEC source: 0001073397-21-000002 · edgardoc.xml · nonDerivative · entry 3 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Partnership Disclosed balance after: 951,943 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2021. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $204.73 to $205.55, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| April 08, 2021 Filed Apr 12, 2021 22:24 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 2,868 | $204.00 | $585,066.84 |
DisclosureSEC source: 0001073397-21-000002 · edgardoc.xml · nonDerivative · entry 2 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Partnership Disclosed balance after: 953,061 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2021. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $203.68 to $204.53, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.